Bebulin is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of Bebulin is Factor IX complex (human).
Bebulin is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.
How do I take it?
Prescribing information states that Bebulin is given as an intravenous injection.
Bebulin comes as a powder that must be reconstituted before injection.
The FDA-approved label for Bebulin lists common side effects including low blood pressure, rash, itching, redness, fever, and chills.
Rare but serious side effects listed for Bebulin include severe hypersensitivity reactions, thromboembolic events, the transmission of infections, and the development of inhibitors.
For more details about this treatment, visit:
Bebulin prescribing information (PDF) – Baxalta
Treatment of Hemophilia – Hemophilia Federation of America